Markets
Pharmaceuticals
The global pharmaceuticals market is expanding in both scale and diversity each year - and customers want new ideas.
Gelteq is well positioned to enter this market as a major competitor of all other medicine and drug delivery systems for pharmaceutical and over-the-counter medications. Our breakthrough gelification process can turn almost any ingredient into a stable, long-lasting gel that your customers will love, making us an ideal new partner to help you launch competitive products or seize our white label opportunities.
Benefits of Gelteq for the market
Due to the sheer scale of the global pharmaceuticals market, and our existing partnerships with major pharma companies Phynova and Reducose, there is considerable opportunity for companies partnering with Gelteq in the sector. Our products have been meticulously researched and are backed by an increasing number of clinical trials, giving our gels a strong marketing advantage.
- The global pharmaceutical industry is expected to grow at a CAGR of 13.74% to 2027.1
- Gelteq products are tested and proven - no need for costly R&D.
- Our gel is protected and exclusive by global patents.
- Gelteq gels enable the delivery of any macro or micronutrients, together with any pharmaceutical, medicinal or nutraceutical ingredients.
1: Grand View Research Market Analysis Report, Pharmaceuticals Market, accessed April 2021
Take advantage of Gelteq
Whether you’re working with powders, tablets, pills, supplements, vitamins or oils, we can transform them into a Gelteq gel.
Our team of experts can sit down with you and help you develop the most effective gel for your company’s needs. If you would like to learn more about how to take advantage of this revolutionary new delivery system, read our gelification page or contact us today.
Take advantage of our hard work.
Seize the opportunity of our new Gelteq delivery system without needing to develop your own individual products. We have a number of white label gels ready to be sold under your brand name, letting you hit the market running without the same R&D.
